Test ID PTTP Prothrombin Time, Plasma
Useful For
Screening assay to detect deficiencies of one or more coagulation factors (factors I, II, V, VII, X)
Screening assay to detect coagulation inhibition
Monitoring intensity of oral anticoagulant therapy when combined with INR reporting
Method Name
Coagulometric (Turbidimetric)
Reporting Name
Prothrombin Time, PSpecimen Type
Plasma Na CitSpecimen Required
Specimen Type: Platelet-poor plasma
Collection Container/Tube: Light-blue top (3.2% sodium citrate)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. For complete instructions see Coagulation Guidelines for Specimen Handling and Processing
2. Centrifuge, remove plasma, and centrifuge plasma again.
3. Aliquot plasma into plastic vial leaving 0.25 mL in the bottom of centrifuged vial.
Additional Information: Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma Na Cit | Frozen (preferred) | 30 days | |
Ambient | 24 hours |
Reference Values
PROTHROMBIN TIME:
9.4-12.5 seconds
INTERNATIONAL NORMALIZED RATIO (INR):
0.9-1.1
Standard intensity warfarin therapeutic range: 2.0-3.0
High intensity warfarin therapeutic range: 2.5-3.5
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 dayPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
85610
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
PTTP | Prothrombin Time, P | 34528-0 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
PTTTP | Prothrombin Time, P | 5902-2 |
INRTP | INR | 6301-6 |